CO2 insufflation
ProcedureFrom the CO2 rack through the endoscopy rack CO2 will be insufflated to visualize the mucosa during oesophagogastroduodenoscopy.
NCT Number: NCT00627211
Comparison on the effect on patient pain and discomfort by using CO2 instead of air for insufflation during gastroscopy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
To achieve a satisfactory examination of the GI tract it needs to be distended during endoscopic procedures. After the examinations many patients complain of abdominal pain and discomfort. This pain has been substantially reduced by substituting room air with CO2 in both colonoscopies and ERCPs. The use of CO2 during colonoscopy has become routine practice at many endoscopy centers.
In our study we will test the hypothesis that abdominal pain after gastroscopies also can be reduced by substituting room air with CO2.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
From the CO2 rack through the endoscopy rack CO2 will be insufflated to visualize the mucosa during oesophagogastroduodenoscopy.
Time frame: 0-48 hours
Time frame: 24 hours
Norwegian Department of Health and Social Affairs
Other Gov
A Double-blinded, Randomized Trial Comparing Carbondioxide(CO2)and Air Insufflation in Oesophago-gastro-duodenoscopy (OGD)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05283980
Acute Pain, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT05468398
Behavior, Health Behavior
Irvine, California, United States
View Trial DetailsNCT03730259
Anxiety, Anxiety Disorders
Orange, California, United States
View Trial DetailsNCT07241988
Anxiety, Anxiety Disorders
İzmir, Balıkesir, Turkey (Türkiye)
View Trial Details